Awesome Chemistry Experiments For 169048-83-3

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.169048-83-3, you can also check out more blogs about169048-83-3

169048-83-3, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 169048-83-3, name is (S)-5-(Chloromethyl)oxazolidin-2-one, introducing its new discovery.

CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are potent CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In formula I, A-B is an arylamide moiety.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.169048-83-3, you can also check out more blogs about169048-83-3

Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H1391NO – PubChem